Hauling in a $100M mega-round, gene therapy startup Generation Bio builds alternative to potentially risky viral vectors
A gene therapy company headed up by bigwigs and backed early on by Atlas has pulled in a mega-round of $100 million. The 2-year-old startup …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
